Literature DB >> 19074875

p53-Responsive micrornas 192 and 215 are capable of inducing cell cycle arrest.

Christian J Braun1, Xin Zhang, Irina Savelyeva, Sonja Wolff, Ute M Moll, Troels Schepeler, Torben F Ørntoft, Claus L Andersen, Matthias Dobbelstein.   

Abstract

microRNAs provide a novel layer of regulation for gene expression by interfering with the stability and/or translation of specific target mRNAs. Overall levels of microRNAs are frequently down-regulated in cancer cells, and reducing general microRNA processing increases cancerogenesis in transgenic models, suggesting that at least some microRNAs might act as effectors in tumor suppression. Accordingly, the tumor suppressor p53 up-regulates miR-34a, a microRNA that contributes to apoptosis and acute senescence. Here, we used array hybridization to find that p53 induces two additional, mutually related clusters of microRNAs, leading to the up-regulation of miR-192, miR-194, and miR-215. The same microRNAs were detected at high levels in normal colon tissue but were severely reduced in many colon cancer samples. On the other hand, miR-192 and its cousin miR-215 can each contribute to enhanced CDKN1A/p21 levels, colony suppression, cell cycle arrest, and cell detachment from a solid support. These effects were partially dependent on the presence of wild-type p53. Antagonizing endogenous miR-192 attenuated 5-fluorouracil-induced accumulation of p21. Hence, miR-192 and miR-215 can act as effectors as well as regulators of p53; they seem to suppress cancerogenesis through p21 accumulation and cell cycle arrest.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19074875      PMCID: PMC2836584          DOI: 10.1158/0008-5472.CAN-08-1569

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  43 in total

Review 1.  Molecular mechanisms of "detachment-induced apoptosis--Anoikis".

Authors:  J Grossmann
Journal:  Apoptosis       Date:  2002-06       Impact factor: 4.677

Review 2.  Transcription-independent pro-apoptotic functions of p53.

Authors:  Ute M Moll; Sonja Wolff; Daniel Speidel; Wolfgang Deppert
Journal:  Curr Opin Cell Biol       Date:  2005-10-13       Impact factor: 8.382

3.  Definition of a consensus binding site for p53.

Authors:  W S el-Deiry; S E Kern; J A Pietenpol; K W Kinzler; B Vogelstein
Journal:  Nat Genet       Date:  1992-04       Impact factor: 38.330

4.  Requirement for p53 and p21 to sustain G2 arrest after DNA damage.

Authors:  F Bunz; A Dutriaux; C Lengauer; T Waldman; S Zhou; J P Brown; J M Sedivy; K W Kinzler; B Vogelstein
Journal:  Science       Date:  1998-11-20       Impact factor: 47.728

5.  Amplification of a gene encoding a p53-associated protein in human sarcomas.

Authors:  J D Oliner; K W Kinzler; P S Meltzer; D L George; B Vogelstein
Journal:  Nature       Date:  1992-07-02       Impact factor: 49.962

6.  ARF-BP1/Mule is a critical mediator of the ARF tumor suppressor.

Authors:  Delin Chen; Ning Kon; Muyang Li; Wenzhu Zhang; Jun Qin; Wei Gu
Journal:  Cell       Date:  2005-07-01       Impact factor: 41.582

7.  Loss of p21 disrupts p14 ARF-induced G1 cell cycle arrest but augments p14 ARF-induced apoptosis in human carcinoma cells.

Authors:  Philipp G Hemmati; Guillaume Normand; Berlinda Verdoodt; Clarissa von Haefen; Anne Hasenjäger; Dilek Güner; Jana Wendt; Bernd Dörken; Peter T Daniel
Journal:  Oncogene       Date:  2005-06-09       Impact factor: 9.867

8.  p53-mediated activation of miRNA34 candidate tumor-suppressor genes.

Authors:  Guido T Bommer; Isabelle Gerin; Ying Feng; Andrew J Kaczorowski; Rork Kuick; Robert E Love; Yali Zhai; Thomas J Giordano; Zhaohui S Qin; Bethany B Moore; Ormond A MacDougald; Kathleen R Cho; Eric R Fearon
Journal:  Curr Biol       Date:  2007-07-26       Impact factor: 10.834

9.  In vivo activation of the p53 pathway by small-molecule antagonists of MDM2.

Authors:  Lyubomir T Vassilev; Binh T Vu; Bradford Graves; Daisy Carvajal; Frank Podlaski; Zoran Filipovic; Norman Kong; Ursula Kammlott; Christine Lukacs; Christian Klein; Nader Fotouhi; Emily A Liu
Journal:  Science       Date:  2004-01-02       Impact factor: 47.728

10.  Real-time quantification of microRNAs by stem-loop RT-PCR.

Authors:  Caifu Chen; Dana A Ridzon; Adam J Broomer; Zhaohui Zhou; Danny H Lee; Julie T Nguyen; Maura Barbisin; Nan Lan Xu; Vikram R Mahuvakar; Mark R Andersen; Kai Qin Lao; Kenneth J Livak; Karl J Guegler
Journal:  Nucleic Acids Res       Date:  2005-11-27       Impact factor: 16.971

View more
  216 in total

Review 1.  MicroRNAs, wild-type and mutant p53: more questions than answers.

Authors:  Matthew Jones; Ashish Lal
Journal:  RNA Biol       Date:  2012-06-01       Impact factor: 4.652

2.  Alteration in miRNA gene expression pattern in acute promyelocytic leukemia cell induced by arsenic trioxide: a possible mechanism to explain arsenic multi-target action.

Authors:  Seyed H Ghaffari; Davood Bashash; Majid Zaki Dizaji; Ardeshir Ghavamzadeh; Kamran Alimoghaddam
Journal:  Tumour Biol       Date:  2011-11-10

Review 3.  Crosstalk between the DNA damage response pathway and microRNAs.

Authors:  Cecil Han; Guohui Wan; Robert R Langley; Xinna Zhang; Xiongbin Lu
Journal:  Cell Mol Life Sci       Date:  2012-03-20       Impact factor: 9.261

Review 4.  Regulation of mammalian microRNA expression.

Authors:  Xiaoxiao Zhang; Yan Zeng
Journal:  J Cardiovasc Transl Res       Date:  2010-02-20       Impact factor: 4.132

Review 5.  MicroRNAs: new players in the DNA damage response.

Authors:  Hailiang Hu; Richard A Gatti
Journal:  J Mol Cell Biol       Date:  2010-12-23       Impact factor: 6.216

Review 6.  The role of microRNAs in colorectal cancer.

Authors:  Aaron J Schetter; Hirokazu Okayama; Curtis C Harris
Journal:  Cancer J       Date:  2012 May-Jun       Impact factor: 3.360

7.  Circulating levels of the miRNAs, miR-194, and miR-29b, as clinically useful biomarkers for colorectal cancer.

Authors:  Gholam Basati; Amirnader Emami Razavi; Iraj Pakzad; Fardin Ali Malayeri
Journal:  Tumour Biol       Date:  2015-08-29

Review 8.  Genomic integrity and the ageing brain.

Authors:  Hei-man Chow; Karl Herrup
Journal:  Nat Rev Neurosci       Date:  2015-10-14       Impact factor: 34.870

9.  Reduced miR-215 expression predicts poor prognosis in patients with acute myeloid leukemia.

Authors:  Yu-Xin Wang; Ting-Juan Zhang; Dong-Qin Yang; Dong-Ming Yao; Lei Yang; Jing-Dong Zhou; Zhao-Qun Deng; Ji-Chun Ma; Hong Guo; Xiang-Mei Wen; Jiang Lin; Jun Qian
Journal:  Jpn J Clin Oncol       Date:  2016-01-21       Impact factor: 3.019

10.  Upregulation of long non-coding RNA NNT-AS1 promotes osteosarcoma progression by inhibiting the tumor suppressive miR-320a.

Authors:  Changhui Li; Shouyun Zhang; Tongguo Qiu; Yuanji Wang; David M Ricketts; Chao Qi
Journal:  Cancer Biol Ther       Date:  2018-11-29       Impact factor: 4.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.